Population‐based cancer staging for oesophageal, gastric, and pancreatic cancer 2012‐2014: International Cancer Benchmarking Partnership SurvMark‐2
- 14 May 2021
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 149 (6) , 1239-1246
Abstract
Cancer stage at diagnosis is important information for management and treatment of individual patients as well as in epidemiological studies to evaluate effectiveness of health care system in managing cancer patients. Population‐based studies to examine international disparities on cancer survival by stage, however, has been challenging due to the lack of international standardization on recording stage information and variation in stage completeness across regions and countries. The International Cancer Benchmarking Partnership (ICBP) previously assessed the availability and comparability of staging information for colorectal, lung, female breast and ovarian cancers. Stage conversion algorithms were developed to aggregate and map all stage information into a single staging system to allow international comparison by stage at diagnosis. In this article, we developed stage conversion algorithms for three additional cancers, namely oesophageal, gastric and pancreatic cancers. We examined all stage information available, evaluated stage completeness, applied each stage conversion algorithm, and assessed the magnitude of misclassification using data from six Canadian cancer registries (Alberta, Manitoba, Newfoundland, Nova Scotia, Prince Edward Island and Saskatchewan). In addition, we discussed five recommendations for registries to improve international cancer survival comparison by stage: (a) improve collection and completeness of staging data; (b) promote a comparable definition for stage at diagnosis; (c) promote the use of a common stage classification system; (d) record versions of staging classifications and (e) use multiple data sources for valid staging data.Keywords
Funding Information
- Cancer Council Victoria
- Cancer Institute NSW
- Cancer Research UK
- Kræftens Bekæmpelse
- Kreftforeningen
This publication has 16 references indexed in Scilit:
- Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyGynecologic Oncology, 2020
- Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- An update on the role of PET/CT and PET/MRI in ovarian cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer RegistriesEpidemiologic Reviews, 2017
- Cancer survival: global surveillance will stimulate health policy and improve equityThe Lancet, 2014
- Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007Acta Oncologica, 2013
- Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007Thorax, 2013
- Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking PartnershipGynecologic Oncology, 2012
- Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgeryGut, 2005
- Influence of stage at diagnosis on survival differences for rectal cancer in three European populationsBritish Journal of Cancer, 1999